Mabascug, Corazon .
HRN: 28-60-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/23/2026
03/01/2026
IV
4.5g
Q8h
Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: